The DOI matches its Crossref record; the references it cites are not checked yet.
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Open accessAbstract
Key Points: A murine model was developed for capsid-specific CD8 cell responses in AAV gene therapy for hemophilia. Y-F mutant capsid minimizes the effect of anticapsid CD8+ T cells on hepatocyte-derived factor IX expression in mice and in human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transfer of expanded and activated capsid-specific T cells to mice resulted in reduced transgene expression and loss of transduced cells [100, 101].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [100]
In the citing paper
“Therefore, mutation of surface tyrosine has been suggested, which resulted in reduced presentation of AAV capsid, decreased T-cell toxicity, and required therapeutic dose [100, 225, 229].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [100]
In the citing paper
“Evidence from early clinical trials, along with subsequent laboratory studies, suggest that CD8+ T cell responses against AAV capsid target transduced hepatocytes (16–18).”
From Effect of CpG Depletion of Vector Genome on CD8+ T Cell Responses in AAV Gene Therapy (2021) · cites this paper as [18]
In the citing paper
“studies in immunodeficient mice,61 canine,62 and non-human primate (NHP)63 models did not mimic human AAV-specific T cell responses.”
From Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells (2021) · cites this paper as [61]
In the citing paper
“One study identi fi ed AAV2(Y-F), a novel capsid generated through phenylalanine (F) for tyrosine (Y) substitutions of several surface-expose tyrosine residues, which achieved more sustained transgene expression and reduced CTL responses against transduced hepatocytes than AAV8 in mice (92).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [92]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 48 · Cited by 162
Metadata
- Authors
- Martino, A. T., Basner-Tschakarjan, E., Markusic, D. M., Finn, J. D., Hinderer, C., Zhou, S., Ostrov, D. A., Srivastava, A., Ertl, H. C. J., Terhorst, C., High, K. A., Mingozzi, F., & Herzog, R. W.
- Affiliations
- St. John's University (US)
- Department of Pediatrics, The Children’s Hospital of Philadelphia and University of Pennsylvania Medical Center, Philadelphia, PA;
- Department of Pediatrics, and
- Children's Hospital of Philadelphia (US)
- University of Florida (US)
- The Wistar Institute (US)
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-03-21
- Volume
- 121
- Issue
- 12
- Pages
- 2224-2233
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3606062
- OpenAlex
- W2044395911
- Cited by
- 162
- References
- 48
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 6 · 2023: 12 · 2022: 8 · 2021: 16 · 2020: 15 · 2019: 10 · 2018: 10 · 2017: 20 · 2016: 13 · 2015: 20 · 2014: 7 · 2013: 13
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (F32HL096281, R01HL097088, P01HL078810)
- National Institute of Allergy and Infectious Diseases (R01AI051390)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01 HD078810)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus vectors, AAV capsid engineering, CD8+ T cells, cytotoxic T lymphocytes, hepatocyte targeting, liver-directed gene therapy, hemophilia, AAV8, MHC class I antigen presentation, hepatotoxicity, adoptive T cell therapy
- MeSH terms
- Dependovirus, Animals, Cells, Cultured, Genetic Engineering, Genetic Vectors, Humans, Male, Mice, Inbred BALB C, Transduction, Genetic, Genetic Therapy, CD8-Positive T-Lymphocytes, Adoptive Transfer, Hepatocytes, Capsid Proteins, T-Cell Antigen Receptor Specificity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. https://app.cochat.ai/papers/10.1182/blood-2012-10-460733
- The paper
- Martino, A. T., Basner-Tschakarjan, E., Markusic, D. M., Finn, J. D., Hinderer, C., Zhou, S., Ostrov, D. A., Srivastava, A., Ertl, H. C. J., Terhorst, C., High, K. A., Mingozzi, F., & Herzog, R. W. (2013). Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Blood. https://doi.org/10.1182/blood-2012-10-460733
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.